Memorial Sloan Kettering Cancer Center: Liver Neoplasms trials

The registry lists 22 Liver Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 0 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 1Phase 2 8Phase 3 3No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver ResectionCompletedNCT01596283Phase 3Results posted
• Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to RadiotherapyCompletedNCT00600613Not applicableResults posted
• A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic MalignancyCompletedNCT00587067Phase 2Results posted
• Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular CarcinomaCompletedNCT00539643Phase 2Results posted
• Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00410956Phase 2Results posted
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsCompletedNCT00024258Phase 2Results posted
• Registry to Collect Health Information Related to Fibrolamellar CancerCompletedNCT04874519
• A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver CancerCompletedNCT03143270Early Phase 1
• A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)WithdrawnNCT02772575
• Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver ResectionActive, not recruitingNCT02523443Phase 3
• A Pilot Study of Perihepatic Phlebotomy During Hepatic ResectionsCompletedNCT01749332Not applicable
• Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of OutcomeActive, not recruitingNCT01494324Not applicable
• The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver MetastasesCompletedNCT01423734
• Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic ResectionCompletedNCT00902343Phase 3
• The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During RadiotherapyCompletedNCT00774501Not applicable
• Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic FunctionWithdrawnNCT00605800
• Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractActive, not recruitingNCT00582647
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal CancerCompletedNCT00200200Phase 2
• Irinotecan and Flavopiridol in Treating Patients With Advanced Liver CancerCompletedNCT00087282Phase 2
• Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically RemovedCompletedNCT00040898Phase 2
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerCompletedNCT00002515Phase 2